AR020559A1 - Compuestos n-oxidos de piridina triciclicos, agonistas de la vasopresina, composicion farmaceutica que los comprende y el uso de los mismos para lamanufactura de un medicamento. - Google Patents
Compuestos n-oxidos de piridina triciclicos, agonistas de la vasopresina, composicion farmaceutica que los comprende y el uso de los mismos para lamanufactura de un medicamento.Info
- Publication number
- AR020559A1 AR020559A1 ARP000100464A ARP000100464A AR020559A1 AR 020559 A1 AR020559 A1 AR 020559A1 AR P000100464 A ARP000100464 A AR P000100464A AR P000100464 A ARP000100464 A AR P000100464A AR 020559 A1 AR020559 A1 AR 020559A1
- Authority
- AR
- Argentina
- Prior art keywords
- vasopresine
- lamanufacture
- piridine
- agonists
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Compuestos N-oxidos de piridina tricíclicos de la siguiente formula general 1 en las cuales se utilizan dichos compuestos y el uso de los mismos para lamanufactura de un medicamento para inducir el retardo temporal de la miccion o para eltratamiento de trastornos que pueden ser remediados o aliviados mediantela actividad agonista de la vasopresina, los cuales incluyen la diabetes insipidus, enuresis nocturna, nocturia, incontinencia urinaria, trastornos de lahemorragia y de lacoagulacion.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24468099A | 1999-02-04 | 1999-02-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR020559A1 true AR020559A1 (es) | 2002-05-15 |
Family
ID=22923704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000100464A AR020559A1 (es) | 1999-02-04 | 2000-02-03 | Compuestos n-oxidos de piridina triciclicos, agonistas de la vasopresina, composicion farmaceutica que los comprende y el uso de los mismos para lamanufactura de un medicamento. |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1149096B1 (es) |
JP (1) | JP2002536374A (es) |
CN (1) | CN1347415A (es) |
AR (1) | AR020559A1 (es) |
AT (1) | ATE229956T1 (es) |
AU (1) | AU2849500A (es) |
CA (1) | CA2358894A1 (es) |
DE (1) | DE60001054T2 (es) |
DK (1) | DK1149096T3 (es) |
ES (1) | ES2188509T3 (es) |
PT (1) | PT1149096E (es) |
WO (1) | WO2000046224A2 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6455554B1 (en) | 1999-06-07 | 2002-09-24 | Targacept, Inc. | Oxopyridinyl pharmaceutical compositions and methods for use |
GB0115515D0 (en) * | 2001-06-25 | 2001-08-15 | Ferring Bv | Oxytocin agonisys |
WO2004096775A1 (ja) | 2003-04-28 | 2004-11-11 | Astellas Pharma Inc. | 4,4-ジフルオロ-1,2,3,4-テトラヒドロ-5h-1-ベンゾアゼピン誘導体又はその塩 |
TWI436988B (zh) * | 2007-03-05 | 2014-05-11 | Transform Pharmaceuticals Inc | 7-〔(3-氯-6,11-二氫-6-甲基二苯并〔c,f〕〔1,2〕噻氮呯-11-基)胺〕庚酸s,s二氧化物之多晶型及其製造與使用方法 |
GB201005623D0 (en) | 2010-04-01 | 2010-05-19 | Vantia Ltd | New polymorph |
AR094929A1 (es) | 2013-02-28 | 2015-09-09 | Bristol Myers Squibb Co | Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2 |
JP6423372B2 (ja) | 2013-02-28 | 2018-11-14 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | 強力なrock1およびrock2阻害剤としてのフェニルピラゾール誘導体 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5849735A (en) * | 1995-01-17 | 1998-12-15 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
AU8592598A (en) * | 1997-07-30 | 1999-02-22 | Wyeth | Tricyclic vasopressin agonists |
-
2000
- 2000-01-13 ES ES00906915T patent/ES2188509T3/es not_active Expired - Lifetime
- 2000-01-13 AT AT00906915T patent/ATE229956T1/de not_active IP Right Cessation
- 2000-01-13 AU AU28495/00A patent/AU2849500A/en not_active Abandoned
- 2000-01-13 CA CA002358894A patent/CA2358894A1/en not_active Abandoned
- 2000-01-13 DK DK00906915T patent/DK1149096T3/da active
- 2000-01-13 PT PT00906915T patent/PT1149096E/pt unknown
- 2000-01-13 WO PCT/US2000/000885 patent/WO2000046224A2/en active IP Right Grant
- 2000-01-13 JP JP2000597294A patent/JP2002536374A/ja active Pending
- 2000-01-13 EP EP00906915A patent/EP1149096B1/en not_active Expired - Lifetime
- 2000-01-13 DE DE60001054T patent/DE60001054T2/de not_active Expired - Fee Related
- 2000-01-13 CN CN00805995A patent/CN1347415A/zh active Pending
- 2000-02-03 AR ARP000100464A patent/AR020559A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA2358894A1 (en) | 2000-08-10 |
AU2849500A (en) | 2000-08-25 |
EP1149096B1 (en) | 2002-12-18 |
DE60001054D1 (de) | 2003-01-30 |
JP2002536374A (ja) | 2002-10-29 |
ATE229956T1 (de) | 2003-01-15 |
EP1149096A2 (en) | 2001-10-31 |
CN1347415A (zh) | 2002-05-01 |
ES2188509T3 (es) | 2003-07-01 |
DK1149096T3 (da) | 2003-04-07 |
DE60001054T2 (de) | 2003-07-24 |
PT1149096E (pt) | 2003-03-31 |
WO2000046224A3 (en) | 2000-12-07 |
WO2000046224A2 (en) | 2000-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1135153T3 (da) | Anvendelser af EPH-receptorantagonister og -agonister til behandling af vaskulære forstyrrelser | |
CO5011096A1 (es) | Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs | |
MX2009004203A (es) | Combinaciones de paracetamol/ibuprofeno y metodo para su uso. | |
BR0113331A (pt) | Derivados de fenilalanina ou seus sais parmaceuticamente aceitáveis, antagonista de integrina alfa 4, agente terapêutico ou agente preventivo para doenças inflamatórias, e, composição farmacêutica | |
PL357944A1 (en) | Intradermal-penetration agents for topical local anesthetic administration | |
EE200300033A (et) | Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon | |
CO5680109A1 (es) | Compuestos para el tratamiento de la disfuncion sexual femenina | |
BG105568A (en) | Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent | |
PA8435001A1 (es) | Derivados 6,6-heterobiciclicos sustituidos. | |
SE0002754D0 (sv) | New pharmaceutical combination formulation and method of treatment with the combination | |
NO20043871L (no) | Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid | |
NZ502449A (en) | Tricyclic vasopressin agonists and their pharmaceutical use | |
AR025883A1 (es) | Utilizacion de antagonistas de los receptores de los cannabinoides centrales para la preparacion de medicamentos | |
EE05127B1 (et) | Osadest koosnev komplekt ja ravimpreparaat, mis sisaldavad P2T-retseptori antagonisti v?i selle farmatseutiliselt vastuv?etavat derivaati ja tromboosivastast ainet, ning nende kasutamine meditsiinis | |
MA33463B1 (fr) | Compositions à dose pharmaceutique solide fixe comprenant de l'irbésartan et de l'amlodipine, leur préparation et leur application thérapeutique | |
AR045783A1 (es) | Composición farmacéutica que comprende un antagonista del receptor p2x7 y una droga anti-inflamatoria no esteroide | |
WO2002034267A8 (de) | Kombination eines transdermalen therapeutischen systems und einer oralen und/oder parenteralen zubereitung enthaltend dopaminagonisten zur behandlung dopaminerger erkrankungen | |
AR020559A1 (es) | Compuestos n-oxidos de piridina triciclicos, agonistas de la vasopresina, composicion farmaceutica que los comprende y el uso de los mismos para lamanufactura de un medicamento. | |
AR033390A1 (es) | Una composicion farmaceutica que comprende un antagonista del receptor at1 y un potenciador de la secrecion de insulina, el uso de dicha composicion para la fabricacion de un medicamento y un kit de partes | |
WO2001017558A3 (en) | Novel uses of mammalian ccr6 receptors and related reagents | |
SE9903995D0 (sv) | New combination | |
CO5200833A1 (es) | Regimenes de dosificacion para lasofoxifeno | |
CL2002001701A1 (es) | Uso de al menos un compuesto seleccionado entre melatonina, agentes melatoninergicos, agonistas y antagonistas de melatonina, en una cantidad de 0,0025-50 mg, para preparar un medicamento util para el tratamiento y mejora de la calidad repadora del sueno. | |
EA200200914A1 (ru) | Система контроля дозирования для однократного ежедневного приема назначенного ципрофлоксацина | |
BR9811559A (pt) | Agonistas tricìclicos de vasopressina |